Literature DB >> 12777478

Arming the enemy: the evolution of resistance to self-proteins.

Graham Bell1, Pierre-Henri Gouyon2.   

Abstract

A remarkable range of novel antibiotics is attracting increasing interest as a major new weapon in the campaign against bacterial infection. They are based on the toxic peptides that provide the innate immune system of animals, and it is claimed that bacteria will be unable to evolve resistance to them because they attack the 'Achilles' heel' of bacterial membrane structure. Both experimental evidence and theoretical arguments suggest that this claim is doubtful. If so, the introduction of these substances into general use may provoke the evolution of resistance to our own defence proteins and thus compromise our natural defences against infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12777478     DOI: 10.1099/mic.0.26265-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  38 in total

Review 1.  Antimicrobial peptides from marine invertebrates.

Authors:  J Andy Tincu; Steven W Taylor
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

2.  Therapeutic antimicrobial peptides may compromise natural immunity.

Authors:  Michelle G J L Habets; Michael A Brockhurst
Journal:  Biol Lett       Date:  2012-01-25       Impact factor: 3.703

3.  Experimental evolution of resistance to an antimicrobial peptide.

Authors:  Gabriel G Perron; Michael Zasloff; Graham Bell
Journal:  Proc Biol Sci       Date:  2006-01-22       Impact factor: 5.349

Review 4.  Perspectives on the evolutionary ecology of arthropod antimicrobial peptides.

Authors:  Jens Rolff; Paul Schmid-Hempel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-05-26       Impact factor: 6.237

5.  Differential adaptive responses of Staphylococcus aureus to in vitro selection with different antimicrobial peptides.

Authors:  Tahsina Shireen; Madhuri Singh; Tiyasa Das; Kasturi Mukhopadhyay
Journal:  Antimicrob Agents Chemother       Date:  2013-07-15       Impact factor: 5.191

6.  In vitro potential of equine DEFA1 and eCATH1 as alternative antimicrobial drugs in rhodococcosis treatment.

Authors:  Margot Schlusselhuber; Sascha Jung; Oliver Bruhn; Didier Goux; Matthias Leippe; Roland Leclercq; Claire Laugier; Joachim Grötzinger; Julien Cauchard
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

7.  The PhoQ-activating potential of antimicrobial peptides contributes to antimicrobial efficacy and is predictive of the induction of bacterial resistance.

Authors:  Jason Kindrachuk; Nicole Paur; Carla Reiman; Erin Scruten; Scott Napper
Journal:  Antimicrob Agents Chemother       Date:  2007-10-15       Impact factor: 5.191

Review 8.  The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future.

Authors:  Tessa M Andermann; Jonathan U Peled; Christine Ho; Pavan Reddy; Marcie Riches; Rainer Storb; Takanori Teshima; Marcel R M van den Brink; Amin Alousi; Sophia Balderman; Patrizia Chiusolo; William B Clark; Ernst Holler; Alan Howard; Leslie S Kean; Andrew Y Koh; Philip L McCarthy; John M McCarty; Mohamad Mohty; Ryotaro Nakamura; Katy Rezvani; Brahm H Segal; Bronwen E Shaw; Elizabeth J Shpall; Anthony D Sung; Daniela Weber; Jennifer Whangbo; John R Wingard; William A Wood; Miguel-Angel Perales; Robert R Jenq; Ami S Bhatt
Journal:  Biol Blood Marrow Transplant       Date:  2018-02-19       Impact factor: 5.742

9.  The Mechanism of Action of Antimicrobial Peptides: Lipid Vesicles vs. Bacteria.

Authors:  Manuel N Melo; Miguel A R B Castanho
Journal:  Front Immunol       Date:  2012-08-02       Impact factor: 7.561

10.  Predicting drug resistance evolution: insights from antimicrobial peptides and antibiotics.

Authors:  Guozhi Yu; Desiree Y Baeder; Roland R Regoes; Jens Rolff
Journal:  Proc Biol Sci       Date:  2018-03-14       Impact factor: 5.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.